Coinbase CEO’s Biotech Firm Gets $130M to Fight Aging With AI, Genomics
In brief NewLimit aims to increase healthy lifespan using AI-driven cell reprogramming. The Series B round brings total funding to over $170 million, backed by top tech and VC names. The longevity startup is part of a broader trend of billionaire-backed longevity ventures. NewLimit, a biotechnology startup co-founded by Coinbase CEO Brian Armstrong, has raised […]
Coinbase CEO’s Biotech Firm Gets $130M to Fight Aging With AI, Genomics Read More »